04 Apr A case of MDS with Ring Sideroblasts
Posted at 11:52h
in
Author: Dr. Brittany Margaret-Anne Salter
Reviewer: Dr. Alejandro Garcia-Horton, Assistant Professor (Oncology), McMaster University
Objectives
At the end of the self-assessment module, participants will be able to:
- Describe the mechanism of anemia in patients with lower-risk myelodysplastic syndrome (LR-MDS).
- Explain the diagnostic criteria for MDS with ring sideroblasts
- Describe the available treatments for LR-MDS
CHS Scientific Planning Committee Members (2021-22)
Dr. Joanne Britto – Resident Physician, Hematology-Oncology
Dr. Yan Xu – Fellow Physician, Hematology
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre
Conflicts of Interest: None